On Wednesday, Dr Pepper Snapple Group Inc. (NYSE:DPS)’s shares declined -0.23% to $82.59.
Dr Pepper has a heritage of elevating unique stories and people – such as Romeo Santos, Latin superstar and Grammy-nominated Bachata singer – who break the mold and dare to make the world their own. To continue its celebration of curiosity and individuality, especially among the Hispanic community, Dr Pepper is hosting a private concert featuring Santos on Wednesday, July 15 as part of its “Dare to Discover” campaign. The exclusive event kicks off the brand’s presence at this year’s Premios Juventud and dares fans to discover the unique flavors of Dr Pepper – and life in general.
This month, Dr Pepper has chosen two outstanding students to receive $75,000 in scholarships as part of the “Dare to Discover” campaign, which encourages Hispanic students to follow their dreams and reach for their aims. The annual scholarship program targets high school seniors of Hispanic heritage who are pursuing a higher education, ultimately selecting recipients based on academic achievement, financial need and an essay submission.
Dr Pepper Snapple Group, Inc. operates as a brand owner, manufacturer, and distributor of non-alcoholic beverages in the United States, Canada, Mexico, and the Caribbean. The company operates through three segments: Beverage Concentrates, Packaged Beverages, and Latin America Beverages.
Pinnacle Entertainment, Inc (NYSE:PNK)’s shares dropped -0.99% to $38.90.
Pinnacle Entertainment, Inc. (PNK) stated financial results for the second quarter ended June 30, 2015.
2015 Second Quarter Highlights:
- Net revenues raised by $26.8 million or 4.8% year over year to a record $582.0 million and Merged Adjusted EBITDA raised by $13.7 million or 9.7% year over year to $154.3 million, inclusive of $0.6 million of cost related to the Lake Charles team member retention program and $0.6 million from cost and lost business volume related to flooding of the Red River in Bossier City. Merged Adjusted EBITDA margin raised by 120 basis points to 26.5%.
- 2015 second quarter performance was driven by strong year over year enhances in Adjusted EBITDA at the properties in the Company’s Midwest segment, particularly at Kansas City, St. Charles, River City, and Belterra Resort. South segment performance was led by Adjusted EBITDA growth at Baton Rouge and Vicksburg, while the West segment was driven by the strong performance of Black Hawk.
- Income from ongoing operations raised by $18.1 million to $15.8 million from a loss of $2.3 million in the preceding year period. Income from ongoing operations margin raised by 310 basis points to 2.7% from (0.4)% in the preceding year period. GAAP diluted net income per share was $0.34 as compared to a loss per share of $0.04 in the preceding year period. Adjusted income per share raised to $0.41 from $0.37 in the preceding year period.
Pinnacle Entertainment, Inc. owns, develops, and operates casinos and related hospitality and entertainment facilities in the United States. Its Midwest segment operates Ameristar Council Bluffs, Ameristar East Chicago, Ameristar Kansas City, Ameristar St. Charles, Belterra, Belterra Park, and River City properties.
At the end of Wednesday’s trade, Popular Inc (NASDAQ:BPOP)‘s shares dipped -2.10% to $30.24.
Popular, Inc. (BPOP) stated net income of $597.5 million and adjusted net income of $90.1 million for the quarter ended June 30, 2015, contrast to net income of $74.8 million and an adjusted net income of $90.3 million for the quarter ended March 31, 2015.
NoteworthyEvents
- During the quarter ended June 30, 2015, the Corporation recorded a partial reversal of the valuation allowance on its deferred tax assets from its U.S. operations for about $544.9 million. The Corporation has concluded that it is more likely than not that a portion of the total of $1.2 billion on deferred tax assets at the U.S. operations, comprised mainly of net operating losses (“NOLs”) will be realized. The Corporation based its determination on its estimated earnings for the remaining carryforward period – eighteen years startning with the 2016 fiscal year – accessible to utilize the deferred tax asset to reduce its income tax obligations.
The enhance in the net deferred tax asset did not have a material impact on regulatory capital. However, it raised the tangible book value per common share by $5.27.
Popular, Inc., through its auxiliaries, provides various retail and commercial banking products and services primarily to institutional and retail customers. The company accepts various deposit products. It also offers commercial and industrial loans; commercial real estate loans; construction loans; lease financing comprising automobile loans/leases; residential mortgage and construction loans; and consumer loans, counting personal loans, credit cards, home equity lines of credit, and other loans to individual borrowers.
Arrowhead Research Corp (NASDAQ:ARWR), ended its Wednesday’s trading session with -3.48% loss, and closed at $5.55.
Arrowhead Research Corporation (ARWR) declared financial results for its fiscal 2015 third quarter ended June 30, 2015.
Fiscal 2015 Third Quarter and Recent Company Highlights
ARC-520
- Received regulatory permission to initiate three multiple-dose Phase 2b studies in the United States (Heparc-2004) and in Germany and Hong Kong (Heparc-2002 and 2003)
- Accomplished dosing of four cohorts in a single-dose Phase 2a study (Heparc-2001) and expanded the study to comprise three additional cohorts
- Accomplished dosing in a non-clinical study in chronically infected chimpanzees that spanned more than a year
- Highlights of the Phase 2a and chimpanzee studies to be presented at an analyst day planned for September 24, 2015
Arrowhead Research Corporation develops novel drugs to treat intractable diseases in the United States. The company’s principal product candidates comprise ARC-520, an RNAi-based therapeutic that is in Phase IIa clinical trial to treat chronic hepatitis B virus infection; and ARC-AAT, a novel unlocked nucleobase analog containing RNAi-based therapeutic for the treatment of liver disease associated with alpha-1 antitrypsin deficiency. Its platform technology comprise Dynamic Polyconjugate platform, an RNAi delivery system that addresses multiple organ systems and cell types.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
